SSY Group 2005.HK · HKD

Its shares trade on HKEX under the ticker 2005.HK. It has been listed since 20 December 2005. In the fiscal year to 31 December 2025, it reported revenue of HK$4.17bn and net income of HK$470.6m. At that date it held total assets of HK$12.81bn and shareholders' equity of HK$7.30bn.

SSY Group Ltd. is an investment holding company, which engages in the research, development, and manufacture of pharmaceutical products. The company employs 4,800 full-time employees The company went IPO on 2005-12-20. The Company’s main products include finished medicines of mainly intravenous infusion solution to hospitals and distributors, bulk pharmaceuticals and medical materials. The Company’s products mainly include non-PVC (Polyvinyl chloride) soft bag infusion solution, PP (Polypropylene) plastic bottle infusion solution and Glass bottle infusion solution. The Company’s products also include Hydrochloride Betahistine, Hydrochloride Ambroxol and Doxofylline as well as bulk pharmaceuticals including caffeine, theophylline, aminophylline, metronidazole and nifedipine.

Figures and description from our data supplier, not checked against the company's own report.

• Mr. Jiguang QuExecutive Chairman of the Board, Chief Executive Officer, since 2005HK$6.7m
• Mr. Hing Yeung ChowChief Financial Officer, Executive Director, Company Secretary, since 2011HK$1.1m
• Mr. Guo MengDeputy General Manager, Executive Director, since 2021HK$1.2m
• Ms. Wanrong QuExecutive Director, since 2024
• Mr. Xuejun SuExecutive Director, since 2014HK$1.7m
• Mr. Wenjun LiuNon-Executive Director
• Mr. Kwok Wai ChowIndependent Non-Executive DirectorHK$228,000
• Mr. Guangce JiangIndependent Non-Executive DirectorHK$228,000
• Mr. Yibing WangIndependent Non-Executive DirectorHK$228,000

Overall

57

Environment

60

Social

43

Governance

68

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.